Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Oct 30, 2018 · 10-Q · 30 days after period end · 0001069530-18-000060
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$1.27M | -$2.59M | -$3.52M | -$3.67M |
| EPS Diluted | -$0.11 | -$0.40 | -$0.54 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Oct 30, 2018 · 30 d after period end
